Elena Arzenton

593 total citations
19 papers, 285 citations indexed

About

Elena Arzenton is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Elena Arzenton has authored 19 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Toxicology, 4 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Elena Arzenton's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Drug-Induced Adverse Reactions (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Elena Arzenton is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Drug-Induced Adverse Reactions (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Elena Arzenton collaborates with scholars based in Italy, United States and Switzerland. Elena Arzenton's co-authors include Ugo Moretti, Roberto Leone, Roberto Bonaiuti, Alberto Vaccheri, Oscar Bortolami, Liberata Sportiello, Anita Conforti, Gianluca Trifirò, Domenico Motola and Alfredo Vannacci and has published in prestigious journals such as Psychological Medicine, Frontiers in Pharmacology and British Journal of Clinical Pharmacology.

In The Last Decade

Elena Arzenton

17 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Arzenton Italy 9 58 52 51 50 44 19 285
Yamato Kato Japan 13 105 1.8× 136 2.6× 69 1.4× 41 0.8× 24 0.5× 25 423
Hoi Y. Tong Spain 12 120 2.1× 31 0.6× 86 1.7× 25 0.5× 56 1.3× 26 385
Esther Salgueiro Spain 10 70 1.2× 31 0.6× 85 1.7× 15 0.3× 22 0.5× 30 396
H. Karl Greenblatt United States 8 31 0.5× 25 0.5× 23 0.5× 30 0.6× 37 0.8× 10 231
Judith Cottin France 10 67 1.2× 16 0.3× 17 0.3× 41 0.8× 28 0.6× 23 286
Ryogo Umetsu Japan 13 110 1.9× 168 3.2× 77 1.5× 44 0.9× 26 0.6× 21 467
Natsumi Ueda Japan 13 111 1.9× 150 2.9× 80 1.6× 43 0.9× 18 0.4× 24 468
Naomi T. Jessurun Netherlands 11 58 1.0× 66 1.3× 27 0.5× 16 0.3× 45 1.0× 50 331
Jérémy Jové France 13 38 0.7× 30 0.6× 59 1.2× 44 0.9× 16 0.4× 45 504
Valérie Gras France 11 31 0.5× 35 0.7× 32 0.6× 23 0.5× 10 0.2× 29 371

Countries citing papers authored by Elena Arzenton

Since Specialization
Citations

This map shows the geographic impact of Elena Arzenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Arzenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Arzenton more than expected).

Fields of papers citing papers by Elena Arzenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Arzenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Arzenton. The network helps show where Elena Arzenton may publish in the future.

Co-authorship network of co-authors of Elena Arzenton

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Arzenton. A scholar is included among the top collaborators of Elena Arzenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Arzenton. Elena Arzenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Crescioli, Giada, Niccolò Lombardi, Elena Arzenton, et al.. (2025). Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase®. Aging Clinical and Experimental Research. 37(1). 120–120.
2.
Filippis, Renato de, John M. Kane, Elena Arzenton, et al.. (2024). Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database. Drug Safety. 47(8). 745–757. 3 indexed citations
3.
Cutroneo, Paola Maria, Elena Arzenton, Nicoletta Luxi, et al.. (2024). Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database. BioDrugs. 38(3). 425–448. 10 indexed citations
4.
Casari, Rebecca, et al.. (2024). Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study. Frontiers in Public Health. 12. 1350176–1350176. 2 indexed citations
5.
Motola, Domenico, et al.. (2024). PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study). British Journal of Clinical Pharmacology. 90(4). 1050–1057. 3 indexed citations
6.
Gastaldon, Chiara, Elena Arzenton, Emanuel Raschi, et al.. (2023). Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants. European Psychiatry. 66(S1). S96–S96.
7.
Gastaldon, Chiara, Elena Arzenton, Emanuel Raschi, et al.. (2022). Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database. Psychological Medicine. 53(12). 5645–5653. 10 indexed citations
8.
Gastaldon, Chiara, Georgios Schoretsanitis, Elena Arzenton, et al.. (2022). Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. Drug Safety. 45(12). 1539–1549. 31 indexed citations
9.
Magro, Lara, et al.. (2021). Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database. Frontiers in Pharmacology. 11. 622862–622862. 36 indexed citations
10.
Carnovale, Carla, Faizan Mazhar, Elena Arzenton, et al.. (2019). Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®. Expert Opinion on Drug Safety. 18(11). 1099–1108. 30 indexed citations
11.
Combi, Carlo, Margherita Zorzi, Gabriele Pozzani, Elena Arzenton, & Ugo Moretti. (2019). Normalizing Spontaneous Reports Into MedDRA: Some Experiments With <inline-formula> <tex-math notation="LaTeX">$\mathsf{MagiCoder}$</tex-math> </inline-formula>. IEEE Journal of Biomedical and Health Informatics. 23(1). 95–102. 5 indexed citations
12.
Carnovale, Carla, Marta Gentili, Elena Arzenton, et al.. (2018). Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database. European Journal of Pediatrics. 178(2). 161–172. 4 indexed citations
13.
Combi, Carlo, Margherita Zorzi, Gabriele Pozzani, Ugo Moretti, & Elena Arzenton. (2018). From narrative descriptions to MedDRA: automagically encoding adverse drug reactions. Journal of Biomedical Informatics. 84. 184–199. 21 indexed citations
14.
Lugoboni, Fabio, Antonio Mirijello, Elena Arzenton, et al.. (2018). Does high-dose benzodiazepine abuse really produce liver toxicity? Results from a series of 201 benzodiazepine monoabusers. Expert Opinion on Drug Safety. 17(5). 451–456. 8 indexed citations
15.
Motola, Domenico, Roberto Leone, Ugo Moretti, et al.. (2017). Liver Injury due to Amoxicillin vs. Amoxicillin/Clavulanate: A Subgroup Analysis of a Drug-Induced Liver Injury Case-Control Study in Italy. Florence Research (University of Florence). 3(1). 5 indexed citations
16.
Conforti, Anita, Annalisa Capuano, Oscar Bortolami, et al.. (2016). Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy. British Journal of Clinical Pharmacology. 82(1). 238–248. 66 indexed citations
17.
Arzenton, Elena. (2014). Acute Hepatitis Caused by Green Tea Infusion: A Case Report. 3(4). 6 indexed citations
18.
Arzenton, Elena, et al.. (2012). Acute hepatitis caused by green tea infusion: a case report .. 35(4). 944–944. 2 indexed citations
19.
Perini, Francesco, Elisabetta Galloni, Irene Bolgan, et al.. (2005). Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurological Sciences. 26(5). 310–318. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yamato Kato Breakdown of academic impact, for papers by Hoi Y. Tong Breakdown of academic impact, for papers by Esther Salgueiro Breakdown of academic impact, for papers by H. Karl Greenblatt Breakdown of academic impact, for papers by Judith Cottin Breakdown of academic impact, for papers by Ryogo Umetsu Breakdown of academic impact, for papers by Natsumi Ueda Breakdown of academic impact, for papers by Naomi T. Jessurun Breakdown of academic impact, for papers by Jérémy Jové Breakdown of academic impact, for papers by Valérie Gras
Rankless by CCL
2026